333,746 Shares in Corteva, Inc. (NYSE:CTVA) Purchased by Susquehanna Fundamental Investments LLC

Susquehanna Fundamental Investments LLC purchased a new stake in shares of Corteva, Inc. (NYSE:CTVA - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 333,746 shares of the company's stock, valued at approximately $19,010,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Stonebridge Capital Advisors LLC lifted its holdings in shares of Corteva by 2.2% during the fourth quarter. Stonebridge Capital Advisors LLC now owns 130,779 shares of the company's stock worth $7,449,000 after purchasing an additional 2,810 shares during the period. Integrated Wealth Concepts LLC raised its position in Corteva by 4.4% during the 4th quarter. Integrated Wealth Concepts LLC now owns 20,820 shares of the company's stock worth $1,186,000 after buying an additional 873 shares during the last quarter. Adage Capital Partners GP L.L.C. lifted its stake in Corteva by 17.6% during the 4th quarter. Adage Capital Partners GP L.L.C. now owns 767,137 shares of the company's stock valued at $43,696,000 after acquiring an additional 114,600 shares during the period. MGO One Seven LLC boosted its holdings in shares of Corteva by 5.7% in the 4th quarter. MGO One Seven LLC now owns 7,641 shares of the company's stock valued at $435,000 after acquiring an additional 411 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its stake in shares of Corteva by 97.3% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 1,961,440 shares of the company's stock worth $111,726,000 after acquiring an additional 967,118 shares during the period. Hedge funds and other institutional investors own 81.54% of the company's stock.

Corteva Price Performance

NYSE:CTVA traded up $0.25 during trading hours on Tuesday, hitting $61.81. 3,340,069 shares of the stock were exchanged, compared to its average volume of 3,321,882. The firm's fifty day moving average price is $60.67 and its 200 day moving average price is $60.47. Corteva, Inc. has a 52-week low of $50.01 and a 52-week high of $66.24. The company has a market cap of $42.22 billion, a P/E ratio of 47.92, a P/E/G ratio of 1.68 and a beta of 0.73. The company has a current ratio of 1.45, a quick ratio of 0.93 and a debt-to-equity ratio of 0.08.

Corteva (NYSE:CTVA - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.32 EPS for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a net margin of 5.36% and a return on equity of 7.19%. As a group, equities research analysts anticipate that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Wells Fargo & Company upped their price target on shares of Corteva from $67.00 to $73.00 and gave the company an "overweight" rating in a report on Tuesday, January 28th. Bank of America upped their target price on Corteva from $69.00 to $73.00 and gave the stock a "buy" rating in a research note on Tuesday, February 11th. Royal Bank of Canada lifted their price target on Corteva from $72.00 to $73.00 and gave the company an "outperform" rating in a research report on Friday, February 7th. UBS Group decreased their price target on Corteva from $74.00 to $73.00 and set a "buy" rating for the company in a report on Friday, January 10th. Finally, Barclays raised their price objective on shares of Corteva from $62.00 to $64.00 and gave the stock an "equal weight" rating in a research note on Tuesday, January 21st. One analyst has rated the stock with a sell rating, three have assigned a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $68.13.

Insider Activity

In related news, insider Brian Titus sold 26,560 shares of the stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $63.74, for a total value of $1,692,934.40. Following the completion of the sale, the insider now owns 11,347 shares of the company's stock, valued at approximately $723,257.78. This trade represents a 70.07 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.14% of the company's stock.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.